Furthermore, FP54 demonstrated significant effects on the differentiation markers in leukemia cells, notably increasing both CD11b and CD14 expression at a concentration of 5 μM in NB4 cells; it also increased CD14 expression in MOLM-13 cells although not the CD11b expression (fig. The gene discussed is CD14; the disease is leukemia.